Get the Stockscreener App
18.08
8.04%
-1.58
After Hours:
18.26
0.18
+1.00%
Eton Pharmaceuticals Inc stock is traded at $18.08, with a volume of 415.17K.
It is down -8.04% in the last 24 hours and up +2.44% over the past month.
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has four commercial rare disease products, Alkindi Sprinkle for the treatment of adrenocortical insufficiency; Carglumic Acid for the treatment of hyperammonemia, Betaine Anhydrous for the treatment of homocystinuria; and Nitisinone for the treatment of hereditary tyrosinemia type 1 (HT-1). The Company has three additional product candidates in late-stage development: ET-400, ET-600, and ZENEO hydrocortisone autoinjector.
See More
Previous Close:
$19.66
Open:
$19.8
24h Volume:
415.17K
Relative Volume:
1.21
Market Cap:
$484.86M
Revenue:
$31.38M
Net Income/Loss:
$-6.69M
P/E Ratio:
-69.54
EPS:
-0.26
Net Cash Flow:
$-1.84M
1W Performance:
-12.78%
1M Performance:
+2.44%
6M Performance:
+45.22%
1Y Performance:
+126.00%
1-Day Range:
$18.03
$19.82
1-Week Range:
$18.03
$21.88
52-Week Range:
$7.58
$23.00
Eton Pharmaceuticals Inc Stock (ETON) Company Profile
Name
Eton Pharmaceuticals Inc
Sector
Phone
(847) 787-7361
Address
21925 W. FIELD PARKWAY, DEER PARK, IL
Compare ETON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ETON
Eton Pharmaceuticals Inc
|
18.08 | 527.23M | 31.38M | -6.69M | -1.84M | -0.26 |
|
ZTS
Zoetis Inc
|
142.26 | 62.54B | 9.39B | 2.62B | 2.22B | 5.8121 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.72 | 43.30B | 29.96B | 957.25M | 4.77B | 0.2956 |
|
HLN
Haleon Plc Adr
|
9.08 | 40.08B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
20.02 | 22.98B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
440.06 | 19.90B | 3.08B | 1.24B | 1.07B | 25.61 |
Eton Pharmaceuticals Inc Stock (ETON) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-23-25 | Reiterated | H.C. Wainwright | Buy |
| Jan-10-25 | Initiated | B. Riley Securities | Buy |
| Jan-06-25 | Reiterated | H.C. Wainwright | Buy |
| Sep-04-24 | Resumed | H.C. Wainwright | Buy |
| May-06-24 | Initiated | Craig Hallum | Buy |
| Oct-14-21 | Resumed | B. Riley Securities | Buy |
| Jan-04-21 | Reiterated | H.C. Wainwright | Buy |
| Sep-20-19 | Initiated | B. Riley FBR | Buy |
| Jun-10-19 | Initiated | H.C. Wainwright | Buy |
View All
Eton Pharmaceuticals Inc Stock (ETON) Latest News
Sector ETF performance correlation with Eton Pharmaceuticals Inc.Market Performance Report & Capital Protection Trading Alerts - newser.com
Is Eton Pharmaceuticals Inc. stock a smart buy before Fed meetingTrade Ideas & Community Trade Idea Sharing - newser.com
Is a relief rally coming for Eton Pharmaceuticals Inc. holders2025 Top Decliners & Safe Capital Growth Trade Ideas - newser.com
Eton Pharmaceuticals Inc. stock momentum explainedBuy Signal & Verified Short-Term Plans - newser.com
Automated trading signals detected on Eton Pharmaceuticals Inc.Insider Selling & Real-Time Price Movement Reports - newser.com
Analysts Set Eton Pharmaceuticals, Inc. (NASDAQ:ETON) PT at $29.67 - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded at Zacks Research - Defense World
Eton Pharmaceuticals (NASDAQ:ETON) Upgraded to Hold at Zacks Research - MarketBeat
Should you wait for a breakout in Eton Pharmaceuticals Inc.Weekly Trade Report & Weekly High Potential Stock Alerts - newser.com
Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Receives Average Rating of "Hold" from Brokerages - MarketBeat
How institutional ownership impacts Eton Pharmaceuticals Inc. stockShare Buyback & Free Daily Entry Point Trade Alerts - newser.com
Technical analysis overview for Eton Pharmaceuticals Inc. stockShare Buyback & High Accuracy Swing Trade Signals - newser.com
Weiss Ratings Reaffirms "Sell (D-)" Rating for Eton Pharmaceuticals (NASDAQ:ETON) - MarketBeat
Weiss Ratings Reaffirms “Sell (D-)” Rating for Eton Pharmaceuticals (NASDAQ:ETON) - Defense World
Can a trend reversal in Eton Pharmaceuticals Inc. lead to recovery2025 Trading Recap & Reliable Breakout Forecasts - newser.com
Trend analysis for Eton Pharmaceuticals Inc. this weekEarnings Risk Summary & Real-Time Volume Spike Alerts - newser.com
Is Eton Pharmaceuticals Inc. showing signs of accumulationWeekly Volume Report & Verified Stock Trade Ideas - newser.com
How Eton Pharmaceuticals Inc. stock benefits from tech adoptionInflation Watch & Smart Money Movement Alerts - newser.com
Is Eton Pharmaceuticals Inc. stock a contrarian buyOil Prices & Smart Swing Trading Alerts - newser.com
Why Investors Shouldn't Be Surprised By Eton Pharmaceuticals, Inc.'s (NASDAQ:ETON) 27% Share Price Surge - 富途牛牛
Real time breakdown of Eton Pharmaceuticals Inc. stock performanceJuly 2025 Patterns & Community Supported Trade Ideas - newser.com
Is Eton Pharmaceuticals Inc a good long term investmentBreakout Stock Watch & Grow Steadily With Our Wealth Roadmap - earlytimes.in
Eton Pharmaceuticals (NASDAQ:ETON) Stock Price Down 5.4%Should You Sell? - MarketBeat
Eton Pharmaceuticals Hits New 52-Week High of $23.00, Up 503.61% - Markets Mojo
Eton Pharmaceuticals (NASDAQ:ETON) Reaches New 52-Week High on Analyst Upgrade - Defense World
What drives Eton Pharmaceuticals Inc stock priceBollinger Bands Signals & Maximize ROI With Proven Growth Stocks - earlytimes.in
Eton Pharmaceuticals (NASDAQ:ETON) Sets New 52-Week High on Analyst Upgrade - MarketBeat
Eton Pharmaceuticals Inc Stock (ETON) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.42%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):